Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05724953 · ClinicalTrials.gov registry record · Phase 1
Alexithymia Intervention for Suicide
A Phase 1 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT05724953: Clinical Trial Phase 1 study, sponsored by VA Office of Research and Development.
NCT05724953 is a Phase 1 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05724953, a Phase 1 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Suicide rates among Veterans with Serious Mental Illness (SMI) are intractably high, representing a serious public health concern and a critical target for interventions. Yet, at present available treatments offer modest benefits. Thus, there remains an urgent need to identify novel approaches to address suicide risk in this population. Previous reports have linked suicide risk with poor social functioning. Emerging evidence from basic affective neuroscience research has indicated that effective social functioning is contingent on intact emotion awareness. Consistent with these findings, individuals with SMI at risk of suicide display social functioning difficulties along with poor emotion awareness (i.e., alexithymia). Employing a proof-of-concept design, the aim of the present study is to test the feasibility and acceptability of a novel, blended psychoeducation and digital mHealth (mobile health) intervention with smartphones designed to target alexithymia and poor social functioning to reduce suicide risk in Veterans with SMI.
Interventions
- BEHAVIORAL Affective Awareness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-01-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05724953
The ClinicalTrials.gov registry entry for NCT05724953 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Affective Awareness is the first listed.
NCT05724953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05724953 about?
NCT05724953 is a clinical study titled "Alexithymia Intervention for Suicide". Suicide rates among Veterans with Serious Mental Illness (SMI) are intractably high, representing a serious public health concern and a critical target for interventions. Yet, at present available treatments offer modest benefits. Thus, there remains an urgent need to identify novel approaches to ad...
What is the current status of trial NCT05724953?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2023-10-01. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT05724953?
The interventions under investigation include: Affective Awareness (BEHAVIORAL).
Who is sponsoring clinical trial NCT05724953?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.